About NED Medical
NED Medical is a company based in Norwell (United States) founded in 2022 by Andy Thoreson and Richard Yazbeck.. NED Medical has raised $1.8 million across 1 funding round. NED Medical offers products and services including CombiSphere. NED Medical operates in a competitive market with competitors including MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, NEXTBIOMEDICAL and MegaPro Biomedical, among others.
- Headquarter Norwell, United States
- Founders Andy Thoreson, Richard Yazbeck
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ned Medical Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.8 M (USD)
in 1 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Aug 28, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NED Medical
NED Medical offers a comprehensive portfolio of products and services, including CombiSphere. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Y90 therapy for liver cancer with optimized features for improved tumor coverage.
Funding Insights of NED Medical
NED Medical has successfully raised a total of $1.8M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.8 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.8M
-
First Round
First Round
(28 Aug 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Seed - NED Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NED Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NED Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ned Medical Comparisons
Competitors of NED Medical
NED Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, NEXTBIOMEDICAL and MegaPro Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| domain | founded_year | HQ Location |
Therapies for fibrosis, cirrhosis, and liver cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provides therapeutics for chronic liver disorder
|
|
| domain | founded_year | HQ Location |
Manufacturer of drug and delivery system for wound dressing for gastrointestinal bleeding
|
|
| domain | founded_year | HQ Location |
Developer of niche-type nano-drugs for cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ned Medical
Frequently Asked Questions about NED Medical
When was NED Medical founded?
NED Medical was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is NED Medical located?
NED Medical is headquartered in Norwell, United States. It is registered at Norwell, Massachusetts, United States.
Who is the current CEO of NED Medical?
Richard Yazbeck is the current CEO of NED Medical. They have also founded this company.
Is NED Medical a funded company?
NED Medical is a funded company, having raised a total of $1.8M across 1 funding round to date. The company's 1st funding round was a Seed of $1.8M, raised on Aug 28, 2023.
What does NED Medical do?
Developer of embolisation-based technology for cancer treatment. It offers combisphere which is a radioembolic microsphere that reduces and eliminates the side effects and toxicities of chemotherapies for treating liver tumors.
Who are the top competitors of NED Medical?
NED Medical's top competitors include MiNA Therapeutics, Alentis Therapeutics and Hepion Pharmaceuticals.
What products or services does NED Medical offer?
NED Medical offers CombiSphere.